Suppr超能文献

脑膜炎奈瑟菌中NadA的多样性与携带情况

NadA diversity and carriage in Neisseria meningitidis.

作者信息

Comanducci Maurizio, Bambini Stefania, Caugant Dominique A, Mora Marirosa, Brunelli Brunella, Capecchi Barbara, Ciucchi Laura, Rappuoli Rino, Pizza Mariagrazia

机构信息

IRIS, Chiron Vaccines, via Fiorentina 1, 53100 Siena, Italy.

出版信息

Infect Immun. 2004 Jul;72(7):4217-23. doi: 10.1128/IAI.72.7.4217-4223.2004.

Abstract

NadA is a novel vaccine candidate recently identified in Neisseria meningitidis and involved in adhesion to host tissues. The nadA gene has been found in approximately 50% of the strains isolated from patients and in three of the four hypervirulent lineages of non-serogroup A strains. Here we investigated the presence of the nadA gene in 154 meningococcal strains isolated from healthy people (carrier strains). Only 25 (16.2%) of the 154 carrier isolates harbored the nadA gene. The commensal species Neisseria lactamica was also found not to have the nadA gene. Eighteen of the carrier strains belonged to the ET-5 and ET-37 hypervirulent clusters, indicating that only the 5.1% of the genuine carrier population actually harbored nadA (7 of 136 strains). Five of the seven strains harbored a novel allele of the nadA gene that was designated nadA4. The NadA4 protein was present on the bacterial surface as heat-stable high-molecular-weight oligomers. Antibodies against the recombinant NadA4 protein were bactericidal against homologous strains, whereas the activity against other NadA alleles was weak. In conclusion, the nadA gene segregates differently in the population of strains isolated from healthy individuals and in the population of strains isolated from patients. The presence of NadA can therefore be used as a tool to study the dynamics of meningococcal infections and understand why this bacterium, which is mostly a commensal, can become a severe pathogen.

摘要

NadA是最近在脑膜炎奈瑟菌中发现的一种新型疫苗候选物,参与对宿主组织的黏附。已在从患者分离出的约50%的菌株以及非A群菌株的四个高毒力谱系中的三个中发现了nadA基因。在此,我们调查了从健康人分离出的154株脑膜炎球菌菌株(携带菌株)中nadA基因的存在情况。154株携带菌株分离物中只有25株(16.2%)含有nadA基因。共生菌乳酸奈瑟菌也被发现没有nadA基因。18株携带菌株属于ET-5和ET-37高毒力簇,这表明只有5.1%的真正携带菌群体实际含有nadA(136株中的7株)。7株菌株中的5株含有nadA基因的一个新等位基因,被命名为nadA4。NadA4蛋白以热稳定的高分子量寡聚体形式存在于细菌表面。针对重组NadA4蛋白的抗体对同源菌株具有杀菌活性,而对其他NadA等位基因的活性较弱。总之,nadA基因在从健康个体分离出的菌株群体和从患者分离出的菌株群体中的分布不同。因此,NadA的存在可作为一种工具来研究脑膜炎球菌感染的动态,并理解为什么这种主要作为共生菌的细菌会成为一种严重病原体。

相似文献

1
NadA diversity and carriage in Neisseria meningitidis.脑膜炎奈瑟菌中NadA的多样性与携带情况
Infect Immun. 2004 Jul;72(7):4217-23. doi: 10.1128/IAI.72.7.4217-4223.2004.
6
Neisseria adhesin A variation and revised nomenclature scheme.淋病奈瑟菌黏附素A变异及修订命名方案。
Clin Vaccine Immunol. 2014 Jul;21(7):966-71. doi: 10.1128/CVI.00825-13. Epub 2014 May 7.

引用本文的文献

3
Presentations at the UK National Immunisation Conference.在英国国家免疫会议上的发言
Hum Vaccin Immunother. 2022 Dec 30;18(7):2087411. doi: 10.1080/21645515.2022.2087411. Epub 2022 Nov 28.
4
The Host-Pathogen Interactions and Epicellular Lifestyle of .. 的宿主-病原体相互作用和上皮细胞生活方式
Front Cell Infect Microbiol. 2022 Apr 22;12:862935. doi: 10.3389/fcimb.2022.862935. eCollection 2022.
5
Product review on the IMD serogroup B vaccine Bexsero®.关于 IMD 血清群 B 疫苗 Bexsero®的产品评价。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020043. doi: 10.1080/21645515.2021.2020043. Epub 2022 Feb 22.

本文引用的文献

3
Development of vaccines against meningococcal disease.抗脑膜炎球菌病疫苗的研发。
Lancet. 2002 Apr 27;359(9316):1499-508. doi: 10.1016/S0140-6736(02)08416-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验